Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
48.7M
-
Shares change
-
+1.93M
-
Total reported value, excl. options
-
$2.56B
-
Value change
-
+$107M
-
Put/Call ratio
-
0.83
-
Number of buys
-
135
-
Number of sells
-
-97
-
Price
-
$52.47
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2020
281 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.7M shares
.
Largest 10 shareholders include BlackRock Inc. (7.02M shares), VANGUARD GROUP INC (4.38M shares), RENAISSANCE TECHNOLOGIES LLC (2.85M shares), MACQUARIE GROUP LTD (2.03M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.66M shares), Spyglass Capital Management LLC (1.53M shares), STATE STREET CORP (1.49M shares), BAILLIE GIFFORD & CO (1.46M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.36M shares), and PAULSON & CO. INC. (1.29M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.